These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

D cell cultures are reshaping and redefining the way medical professionals treat patients. Learn a few interesting facts ...

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study. The experimental approach, which uses tiny capsules called small ...

A report in the journal Science from researchers in the UW–Madison Department of Chemistry represents a significant advance ...

Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...

This manuscript offers valuable insights by identifying two distinct liver cancer subtypes through multi-omics integration and developing a robust prognostic model, validated across various datasets, ...

For instance, 3D IFC has been successfully performed to reveal liver ... the AI model accurately classified and enumerated NK ...

3D titles on Netflix aren’t as commonplace as one might hope. In fact, its library of titles is extremely limited and if Netflix is going to be your only source of watching 3D content, we’d suggest ...

Founded in 2013, with headquarters in the U.S. and research and development (R&D) facilities in Bangalore, the biotech Zumutor Biologics is an immuno-oncology company working in the area of targeted ...

Their collaboration has resulted in engineered cells called ‘synthetic organizers’ that deliver instructions to stem cells, telling them to grow into specific tissues and organs.